In clinical foot care, the gap between what the evidence supports and what patients actually do at home is one of the most persistent obstacles to outcomes. Patients leave clinic appointments with recommendations for daily hygiene routines, appropriate footwear, and consistent application of topical products, and a significant proportion of them don't follow through. Not because they're indifferent to their own care, but because the products available to them either don't work reliably, are cosmetically inconvenient, or require compliance over timelines long enough that motivation erodes.
This is the clinical problem that first led me to look more carefully at aqueous iodine formulations. What I found, and what more than 200 foot care clinics across North America have since incorporated into their daily protocols, is a formulation with a compelling evidence base, practical compliance advantages, and a mechanism of action that addresses several of the most common clinical challenges in foot and nail care simultaneously.
This article summarizes what the clinical evidence shows, how clinics are using IodinePure in daily practice, and what I communicate to patients about the 90-day commitment that makes the difference between intermittent benefit and durable results.
The Clinical Problem: Recurring Foot and Nail Infections in Clinic Patients
Any practitioner who has worked in a foot care clinic for more than a few months will recognise the pattern. Patients present with onychomycosis (thickened, discoloured, brittle nails) or with tinea pedis and interdigital maceration. They've often been managing these conditions for months or years before presenting to a clinic. Some have tried OTC antifungal creams. Some have completed a course of oral terbinafine. Some have done both, with partial or temporary improvement.
The clinical challenge with nail fungal infections in particular is not simply antimicrobial efficacy, it's penetration and consistency. The nail plate is a mechanically dense structure. Topical agents need either formulation technology or sustained daily application over the full nail growth cycle to have meaningful impact on the nail matrix, where the infection is established. A 90-day minimum commitment is the clinical standard for evaluating any topical nail product, and patient adherence over that window is the primary determinant of outcome.
For foot skin (the heels, soles, toe webs, and nail folds) the recurring problem is a compromised skin barrier that never fully recovers between episodes. Once tinea pedis establishes itself, the stratum corneum in affected areas is persistently altered: pH shifts, lipid organization is disrupted, and the local antimicrobial environment that would normally limit re-colonization is diminished. Resolving the acute episode is one job; restoring the barrier to pre-infection function is a second one, and it takes sustained maintenance.
This is the clinical context in which a daily, broad-spectrum, barrier-supporting topical agent becomes genuinely useful: as a daily adjunct that works alongside prescription and OTC antifungal care, reducing the conditions under which recurring infections establish themselves.
Why Standard Treatments Have Limitations
Understanding why foot care clinics have adopted aqueous iodine requires understanding what the standard treatment landscape looks like from a patient management perspective.
Oral antifungals (terbinafine, itraconazole) are effective against onychomycosis and carry the highest success rates of any available treatment. They're also systemic medications with hepatotoxicity considerations, drug interaction profiles, and cost implications that make them unsuitable as a first-line recommendation for mild to moderate presentations, or for patients on complex medication regimens. Many patients with nail fungal infections are older adults managing multiple chronic conditions, precisely the population for whom systemic antifungal therapy requires the most careful consideration.
Prescription topical antifungals (ciclopirox, efinaconazole, tavaborole) represent a genuine advance in topical nail therapy, with penetration profiles that OTC products can't match. But they are expensive, not universally covered by provincial formularies, and require a prescription that many patients either don't seek or can't access readily. Compliance over the 48-week treatment periods these products typically require is also a consistent real-world challenge.
OTC antifungal creams and solutions are appropriate for tinea pedis and early interdigital infections but have limited efficacy against established nail matrix infections where fungal hyphae are embedded beneath the nail plate. They're useful, widely available, and low-risk, but their results for nail involvement are inconsistent at best.
The gap in the treatment landscape is not at the acute treatment end. It's at the daily maintenance and prevention end: a product that patients can use every day, that won't interact with their medications, that supports the barrier and antimicrobial environment of the foot skin, and that is practical enough in its daily use format that they'll actually do it. That is the clinical space aqueous iodine occupies.
The Case for Aqueous Iodine: Evidence Review
The evidence base for topical iodine in skin and nail care is more substantial than many practitioners expect, given how rarely it's highlighted in dermatology curricula. What follows describes iodine as an ingredient, in the preparations the researchers used; IodinePure is a cosmetic and those findings are not performance results for it.
The antifungal activity of iodine against dermatophytes and Candida species has been documented across multiple in vitro and clinical studies. Research reviewed in PMC1569938 reported that aqueous iodine demonstrates consistent activity against the organisms most commonly implicated in tinea pedis and onychomycosis (Trichophyton rubrum, Trichophyton mentagrophytes, and Candida albicans) through oxidative disruption of fungal cell membranes. Critically, this mechanism does not appear to generate resistance patterns of the kind seen with azole antifungals, which is clinically relevant for patients who have had multiple prior treatment courses.
On the wound healing side, PMC4599634 examined outcomes in patients treated with iodine-containing preparations and found that iodine supported healing through both antimicrobial activity and modulation of protease activity in the wound environment. Dilute aqueous formulations, in contrast to high-concentration povidone-iodine, cleared the bacterial and inflammatory debris that impedes tissue regeneration without damaging viable fibroblasts and keratinocytes. This is the distinction that makes aqueous iodine appropriate for daily use on fragile skin, where traditional Betadine at 10% concentration would be contraindicated.
Research published in the Journal of the American Academy of Dermatology has addressed iodine's role in supporting the antimicrobial barrier function of the skin, the layer of lipids, proteins, and pH gradients that prevents surface colonization from progressing to infection. Topical iodine applied regularly appears to support this surface chemistry, particularly in patients whose barrier has been disrupted by chronic infection, mechanical stress, or nutritional insufficiency.
Taken together, the evidence supports aqueous iodine as a daily adjunct for: reducing surface microbial load on at-risk foot skin; supporting barrier recovery in skin compromised by prior infection; and providing a consistent antimicrobial environment around the nail plate and folds that limits recolonization.
How Clinics Use IodinePure in Daily Practice
The clinical protocol that more than 200 foot care clinics across North America have adopted is straightforward, and its simplicity is part of its value.
At the clinic visit: Practitioners apply IodinePure's EZ Clear Nails directly to the nail plate and surrounding nail folds as part of the standard assessment and treatment visit. The decolorized aqueous format means no staining of clinic linens or patient clothing, a practical advantage that matters when a product is being used across dozens of patient visits per day. Sole Shield is applied to the broader foot skin surface (heels, soles, toe webs) where skin fragility and fungal colonization are most commonly observed.
Patient education for home use: Patients are instructed to incorporate IodinePure into their daily foot hygiene routine: soak feet 3 to 4 times per week; wash and dry feet thoroughly, paying attention to the toe webs; spray EZ Clear Nails to the nail plate and folds twice daily (morning and evening); allow to dry; apply Sole Shield to the soles and heels; finish with an appropriate moisturizer if indicated. The protocol is simple: Soak. Spray. Repeat. The entire routine takes under five minutes. Patients are advised to spray at the same time each morning and evening, and most find after showering and before bed the most practical.
Frequency and follow-up: Twice-daily spray application and soaks 3 to 4 times per week for a minimum of 90 days is the standard recommendation, with follow-up clinic assessment at 90 days to evaluate nail and skin response. In patients with severe nail involvement or significantly compromised skin barrier, the protocol may be extended or supplemented with prescription antifungal therapy as clinically indicated.
The decolorized, non-staining formulation of IodinePure is not an incidental feature, it is the primary compliance driver. Patients who have previously encountered traditional iodine preparations remember the brown staining and won't repeat the experience. Removing that barrier is what makes the 90-day commitment achievable for the majority of patients.
Patient Outcomes I've Observed
I want to be precise about what I'm describing here: these are clinical observations from practice, not controlled trial outcomes. IodinePure is listed with Health Canada as a cosmetic, and I describe it in those terms, by what patients and I can see. What follows is what I have observed in patients who have followed the daily protocol consistently.
Patients who complete the 90-day protocol consistently report improvements in the appearance of affected nails: reduced discolouration, improved nail plate texture, and in some cases visible clearing beginning at the nail base as new growth emerges. These observations are consistent with what you would expect from a daily topical applied to the nail folds and plate surface over the period of new nail growth.
On the skin side, patients with chronic heel fissures and recurring tinea pedis report that the combination of daily aqueous iodine application and appropriate moisturization produces more durable improvement than moisturizer alone, consistent with the hypothesis that barrier support, not just hydration, is what these patients need to maintain skin integrity between clinic visits.
Perhaps the most consistent observation is the one that's hardest to quantify: patients who establish a daily foot hygiene routine with a product they're willing to use become more engaged in their own foot health overall. They notice changes earlier. They present to follow-up appointments more reliably. And they're more likely to pair the IodinePure protocol with the footwear, moisture management, and infection prevention habits that determine long-term outcomes.
Why Aqueous vs. Traditional Iodine Formulations
This distinction is worth examining carefully, because it comes up in nearly every clinical conversation about iodine.
Betadine (povidone-iodine at 10%) is a surgical antiseptic developed for pre-operative skin preparation, where the goal is maximum microbial reduction on intact skin before a single procedure. At that concentration, it achieves that goal effectively. It also impairs fibroblast proliferation and keratinocyte migration, both essential to wound healing, and it stains everything it contacts brown. None of these properties make it appropriate for daily use on fragile, fissured, or repeatedly compromised skin.
Aqueous iodine at the concentrations used in IodinePure formulations delivers active iodine molecules without the polymer carrier system that makes povidone-iodine cytotoxic at high concentrations. The antimicrobial activity of the ingredient is preserved; the tissue toxicity and staining are eliminated. This is not a minor formulation difference, it is the difference between a product that is appropriate for daily clinical and home use and one that is not.
Decolorization is the other critical formulation feature. The brown colour of iodine is not the active antimicrobial agent, it is a visual property of the iodine molecule in its less reactive state. Decolorization does not reduce activity; it removes the cosmetically unacceptable property that would otherwise make daily use impractical for most patients. For any protocol that depends on 90 consecutive days of patient compliance, this is not a cosmetic nicety, it is a clinical prerequisite.
The Iodine Deficiency Dimension: Why Topical Application Makes Sense
There is an additional dimension to the clinical rationale for topical iodine that is underappreciated in practice: the role of iodine deficiency in skin fragility.
Iodine deficiency, even at subclinical levels, affects skin integrity through both systemic and local pathways. Systemically, insufficient iodine reduces thyroid hormone production, which slows the metabolic processes that drive skin cell renewal, collagen synthesis, and sebaceous output. The clinical result is skin that is dry, brittle, and slow to heal, presentations that are familiar in any foot care clinic and that are often attributed to aging or environmental factors rather than nutritional insufficiency.
Locally, iodine contributes to the antimicrobial environment of the skin surface through iodination of lipids and proteins in the stratum corneum. When iodine availability is reduced, this aspect of the skin's innate immune function is compromised, making it easier for organisms like Trichophyton and Candida to establish colonization on already-compromised skin.
Topical aqueous iodine addresses the local dimension directly, delivering iodine to the skin surface where it supports antimicrobial barrier function and helps maintain the surface environment necessary for healthy tissue. Dietary iodine adequacy is its own separate matter, but for patients whose foot skin is already compromised, local application through daily topical use provides a meaningful adjunct to the barrier recovery process.
What I Tell Patients About the 90-Day Protocol
Managing patient expectations around the 90-day commitment is, in my experience, the most important conversation in the entire clinical encounter around nail and skin care.
The nails grow slowly. Complete replacement of the nail plate takes six to twelve months depending on age and health status. Any topical product, whether IodinePure, a prescription antifungal lacquer, or anything else, works by influencing the nail matrix environment and the new growth that emerges from it. Patients who expect to see dramatic changes within two weeks will be disappointed and will stop the protocol. Patients who understand that improvement is visible in new growth, and that new growth takes time, maintain their compliance and see results.
I tell patients: look at the base of the nail, the new growth closest to the cuticle, at 60 and 90 days. That is where you'll see improvement first. The discoloured nail that's been there for two years is not going to change quickly; it will grow out over months as healthy new nail replaces it. What you're building is a daily habit that changes the environment the new nail grows into.
I also tell patients that the protocol works best hand in hand with professional care. Regular clinic visits for nail debridement, skin assessment, and barrier management remain essential for patients with significant nail involvement or compromised skin integrity. IodinePure supports the daily maintenance work between those visits, and that daily consistency is what makes clinic-visit outcomes durable rather than temporary.
A Daily Clinical Tool
I want to close with the framing I use in every clinical conversation about IodinePure: this is the daily maintenance layer that sits alongside professional care, and the two work best together. Health Canada has it listed as a cosmetic, which is the appropriate regulatory category for a product that supports healthy skin appearance as part of a daily hygiene routine.
What the evidence supports, and what clinical practice across 200+ foot care clinics in North America has demonstrated, is that consistent daily application of an aqueous iodine formulation (non-staining, non-irritating, and designed for the specific demands of foot skin and nail care) provides a meaningful contribution to the maintenance of skin and nail health in patients who are managing recurring infections, chronic skin fragility, and the barriers to consistent self-care that make these conditions so difficult to resolve.
For patients who are committed to the 90-day protocol, who attend regular follow-up appointments, and who combine daily IodinePure use with appropriate footwear, moisture management, and professional care, the outcomes are consistently better than for those who manage intermittently. That pattern is what the evidence would predict, and it is what I observe in practice.
EZ Clear Nails is available for individual purchase and clinic supply for the 90-day nail and nail fold protocol. Sole Shield is designed for daily foot skin care as a complement to EZ Clear Nails in a complete IodinePure foot care routine. Both are listed with Health Canada as cosmetics.
Evan Lewis, PhD, specializes in natural and nutritional approaches to the prevention and management of chronic diseases and their complications. His research spans chronic disease, diabetes complications, clinical nutrition, and nerve health, including the development of topical iodine approaches for foot care and wound health. IodinePure products are listed with Health Canada as cosmetics.
